© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
Cardiovascular Disease
Ticagrelor Monotherapy Shows Cardiovascular Benefit in Patients with Diabetes
March 31, 2020
Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.
Alirocumab Evaluated for Treatment of Homozygous Familial Hypercholesterolemia
March 31, 2020
Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data.
FDA Grants Fast Track Designation to Empagliflozin for Chronic Kidney Disease
March 17, 2020
Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
Study Finds Habitual Fish Oil Use Linked to Cardiovascular Benefits
March 12, 2020
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.
EHR Data Analysis Suggests Need for Improvement in Blood Pressure Management
March 11, 2020
A new study found several shortcomings in blood pressure management.
Benefits of Hypertension Treatments Largely Similar Across Drug Classes
February 26, 2020
The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.
Analysis: Apixaban Associated with Lower Risks Than Warfarin
February 25, 2020
A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
FDA OKs New Non-Statin, LDL-C Lowering Treatment
February 24, 2020
Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.
Study Adds to Evidence Linking Rosiglitazone to Cardiovascular Risks
February 12, 2020
Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.
Does Blood Pressure, Cholesterol Medication Use Affect Healthy Habits?
February 06, 2020
A new study shows that patients who initiated treatment with blood pressure or cholesterol medications were more likely to reduce activity and gain weight.